This compound is a pharmaceutical intermediate featuring a pyrrolidine ring with bromoacetyl and benzyl ester substituents. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1428243-26-8
(3R,4S)-1-((benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid Dicyclohexylamine Salt
Pharmaceutical intermediate
(3R,4S)-1-((Benzyloxy)carbonyl)-4-ethylpyrrolidine-3-carboxylic acid
Pharmaceutical intermediate
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
Pharmaceutical intermediate
4-Desmethoxy-4-nitro Omeprazole Sulfide
Pharmaceutical intermediate for omeprazole analogs
N1-methylpseudouridine-5'-triphosphate
pharmaceutical intermediate
Fezolinetant Impurity 3
Pharmaceutical intermediate
Benzyl (3S,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical intermediate for synthesis
Sulfoxonium, (2-((3R,4S)-4-ethyl-1-((phenylmethoxy)carbonyl)-3-pyrrolidinyl)-2-oxoethyl)dimethyl-, inner salt, rel-
Pharmaceutical intermediate for synthesis
benzyl (3R,4S)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
QEFUCTKHMXMWRF-KGLIPLIRSA-N
CC[C@@H]1CN(C[C@@H]1C(=O)CBr)C(=O)OCC2=CC=CC=C2